Cardiac Dimensions announced today that it appointed Dr. Satya Shreenivas as its new chief medical officer (CMO). Kirkland, Washington-based Cardiac Dimensions develops minimally invasive treatments for heart failure with functional mitral regurgitation (FMR). That includes the Carillon Mitral Contour System, for which the company has the ongoing EMPOWER trial. Its new CMO served as an […]
Cardiac Dimensions
Cardiac Dimensions raises $35M Series D for mitral contour system
Heart failure treatment developer Cardiac Dimensions announced today that closed a $35 million Series D financing round. Kirkland, Washington-based Cardiac Dimensions develops minimally invasive treatment modalities for heart failure and related cardiovascular conditions. Its lead product, the Carillon Mitral Contour System, uses a gentle, minimally invasive approach. It designed the system to restore natural mitral […]
JenaValve names Kilcoyne as CEO | Personnel Moves – January 15, 2019
JenaValve Technology said today that it named former ReVision Optics prez & CEO John Kilcoyne as its new chief executive officer, effective immediately, replacing Dr. Victoria Carr-Brendell, who has taken up an executive leadership position with Sonova Holding AG (SIX:SOON). Prior to his time at ReVision Optics, Kilcoyne served as prez & CEO at Micrus Endovascular where he […]
Cardiac Dimensions wins German reimbursement for Carillon mitral repair device
Cardiac Dimensions said today that it won reimbursement from Germany’s Institute for the Hospital Remuneration System (InEK) for its Carillon mitral contour system intended to treat patients with functional mitral regurgitation. The Kirkland, Wash.-based company’s percutaneous Carillon device is designed to use a distal anchor and proximal anchor, connected by a shaping ribbon, to re-form the mitral […]
TCT 2018: Cardiac Dimensions meets endpoints in Carillon trial
Here’s a roundup from this week’s Transcatheter Cardiovascular Therapeutics convention in San Diego: Cardiac Dimensions said yesterday that a study of its Carillon mitral valve repair device met its primary endpoint, with the data presented at the annual Transcatheter Cardiovascular Therapeutics meeting in San Diego. Kirkland, Wash.-based Cardiac Dimensions said the Reduce FMR trial was […]
Cardiac Dimensions launches pivotal trial for Carillon mitral repair device
Cardiac Dimensions said today it launched a pivotal trial of the Carillon mitral valve repair device it’s developing, and that it enrolled and randomized its first patient in the trial. The Kirkland, Wash.-based company’s percutaneous Carillon annuloplasty device is designed to use a distal anchor and proximal anchor, connected by a shaping ribbon, to re-form the mitral annulus […]
Medtech companies raised more than $738 million in Q2
Venture capital firms invested more than $738 million during the second quarter of 2018, $1 million less than the first quarter of this year, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There was a total of 61 deals during Q2, an increase from the 48 that the industry saw during Q1. […]